Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer-Reference-Cited by-同舟云学术

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer

Published:2014-06-19 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Akl Elie A¹,Kahale Lara A²,Neumann Ignacio³,Barba Maddalena⁴,Sperati Francesca⁵,Terrenato Irene⁵,Muti Paola⁶,Schünemann Holger⁷

Affiliation:

1. American University of Beirut; Department of Internal Medicine; Riad El Solh St Beirut Lebanon

2. American University of Beirut; Faculty of Medicine; Beirut Lebanon

3. Faculty of Medicine, Pontificia Universidad Católica de Chile; Department of Internal Medicine, Evidence Based Health Care Program; Lira 44, Santiago Santiago Región metropolitana Chile

4. Regina Elena National Cancer Institute; Division of Medical Oncology B - Scientific Direction; Via Elio Chianesi 53 Rome Italy 00144

5. Regina Elena National Cancer Institute; Biostatistics-Scientific Direction; Via Elio Chianesi 53 Rome Italy 00144

6. National Cancer Institute Regina Elena; Department of Epidemiology; Via Elio Chianesi 53 Rome Italy 00144

7. McMaster University; Departments of Clinical Epidemiology and Biostatistics and of Medicine; 1280 Main Street West Hamilton ON Canada L8N 4K1

Publisher

Wiley

Subject

Pharmacology (medical)

Reference84 articles.

1. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis;Breddin;New England Journal of Medicine,2001

2. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism;Buller;New England Journal of Medicine,1997

3. A randomised trial of subcutaneous low molecular weight heparin (CY 216) compared with intravenous unfractionated heparin in the treatment of deep vein thrombosis. A collaborative European multicenter study;Duroux;Thrombosis and Haemostasis,1991

4. Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism;Prandoni;Archives of Internal Medicine,2004

5. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis;Hull;New England Journal of Medicine,1992

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticoagulation for the initial treatment of venous thromboembolism in people with cancer;Cochrane Database of Systematic Reviews;2021-12-08

2. Intracerebral haemorrhage in patients with brain metastases receiving therapeutic anticoagulation;Journal of Neurology, Neurosurgery & Psychiatry;2021-03-09

3. Treatment of venous thromboembolism in cancer patients: a systematic review and meta-analysis on the efficacy and safety of different direct oral anticoagulants (DOACs);Annals of Translational Medicine;2021-01

4. Adjuvant chemotherapy in curatively resected rectal cancer: How valid are the data?;World Journal of Gastrointestinal Oncology;2020-04-15

5. Pharmacological treatment of hepatocellular carcinoma with cavoatrial tumor thrombus – case series and literature review;Zeitschrift für Gastroenterologie;2019-04